Â鶹´«Ă˝×ĘÔ´

NAMEventsAnnual MeetingSpeaker Information

Speaker Information​

This page contains speaker biographies, conflict-of-interest information, and related work.

Annual Meeting

Scientific Program

Introduction & Keynote

Robert and Janice McNair Endowed Chair in Molecular and Human Genetics, Professor and Chair
Baylor College of Medicine

Brendan Lee, MD, PhD, is Professor and Chairman of the Department of Molecular and Human Genetics at Baylor College of Medicine. As a physician scientist, he studies structural birth defects, inborn errors of metabolism, and genomic medicine implementation. He leads multiple NIH clinical research consortia and holds multiple patents in therapeutics. Licensed technologies are in industry-sponsored clinical development for osteoarthritis, Osteogenesis Imperfecta, and Maple Syrup Urine Disease. He has served on multiple advisory panels including on the Advisory Committee to the Director of the NIH. He was an HHMI Investigator prior to becoming Chairman of the DMHG in 2014. The DMHG is a hybrid clinical/basic science/molecular pathology department ranking first in NIH funding for 14 consecutive years among US genetics departments. He also founded Baylor Genetics, a unique academic-commercial joint venture genetic diagnostic laboratory who was among the first to implement clinical multi-omic analyses.

President and CEO
KFF

Drew Altman, PhD, is President and CEO of KFF, a position he has held for more than 30 years since founding the modern day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field. Dr. Altman built KFF with the mission the organization pursues today—to serve as an independent source of trusted information on health policy for policymakers, the media, and the public. He is also founding publisher of KFF Health News, the largest health newsroom in the U.S., which reports on health issues and distributes its original journalism through major news outlets across the country. Dr Altman established KFF Health News in 2009 to address the need for in-depth journalism focusing on the impact of health policy and the changing health system on people. Dr. Altman was commissioner of the Department of Human Services for the state of New Jersey, a state umbrella agency which under his leadership was responsible for a third of the state budget and state employees. There he was nationally recognized for initiatives in welfare reform, school-based health services, community-based HIV health services, and homelessness. He was director of Health and Human Services at The Pew Charitable Trusts, vice president of the Robert Wood Johnson Foundation, and served in a senior position in the Health Care Financing Administration in the Carter administration. He is a member of the National Academy of Medicine and the Council on Foreign Relations and serves on numerous nonprofit boards and advisory committees. He has been a regular contributor to the Wall Street Journal and Axios. Dr. Altman earned his doctorate in political science at the Massachusetts Institute of Technology
and completed his postdoctoral work at Harvard University before moving on to public service. He holds an honorary doctorate from the Morehouse School of Medicine.

Understanding Chronic Disease Development & Risk Across the Lifespan

Dean, Wake Forest University School of Medicine; Chief Academic Officer, Advocate Health
Annual Meeting PANEL MODERATOR

Ebony Boulware, MD, MPH, is Dean of Wake Forest University School of Medicine, Executive Vice President for Academic Health Affairs at Wake Forest University, and Chief Academic Officer for Advocate Health. She leads the academic mission for one of the nation’s largest integrated academic health systems, providing strategic leadership for education, research, faculty affairs, and academic innovation across a six-state organization. Dr. Boulware is a general internist, physician-scientist, and clinical epidemiologist whose research has advanced understanding of the patient-, clinician-, health system-, and community-level factors that shape health outcomes and health equity. Her work has informed national policy, influenced clinical practice, and advanced the translation of scientific discovery into improved health through innovations in research, education, and health system transformation. Dr. Boulware serves on the Governing Council of the National Academy of Medicine and is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Arts and Science.

Scientific Director
National Institute on Aging, National Institutes of Health

Luigi Ferrucci, MD, PhD, Scientific Director, National Institute on Aging (NIA), National Institutes of Health is a geriatrician and an epidemiologist who conducts research on causal pathways leading to progressive physical and cognitive decline in older persons. He has made major contributions in the design of many epidemiological studies conducted in the U.S. and in Europe. Dr. Ferrucci received a Medical Degree and Board Certification in 1980, Board Certification in Geriatrics in 1982 and PhD in Biology and Pathophysiology of Aging in 1998 at the University of Florence, Italy. Between 1985 and 2002 he was Chief of Geriatric Rehabilitation at the Department of Geriatric Medicine and Director of the Laboratory of Clinical Epidemiology at the Italian National Institute of Aging. In September 2002, he became the Chief of the Longitudinal Studies Section at NIA. From 2002 to present he is the Director of the Baltimore Longitudinal Study of Aging. Dr. Ferrucci is currently the Scientific Director of NIA, since May 2011.

Professor, Department of Sociology
The University of Texas at Austin

Bridget Goosby, PhD, is Professor of Sociology and co-director of the LifeHD Health Disparities Research Lab at the University of Texas at Austin. Her research develops and applies biosocial approaches to understand how experiences of racism and other forms of social marginalization become biologically embedded and contribute to health inequities across the life course. Her collaborative work integrates innovative biological measures, ambulatory technologies, and mixed methods approaches with qualitative, survey, and population-based data to illuminate the dynamic interplay between social experiences and physiological processes that shape health and aging. This work has been supported by the Spencer Foundation and the National Institutes of Health. Dr. Goosby is an elected Fellow of the American Association for the Advancement of Science, an elected member of the Sociological Research Association, and the recipient of the University of Michigan Program for Research on Black Americans Career Achievement Award and the Interdisciplinary Association for Population Health Science’s Humana Foundation Excellence in Health Equity Research Award.

Senior Associate Dean of Public Health Data Science and Data Equity; and Anna MR Lauder Professor of Biostatistics
Yale University

Bhramar Mukherjee, PhD, is the Anna M.R. Lauder Professor of Biostatistics at the Yale School of Public Health. Professor Mukherjee serves as the inaugural Senior Associate Dean of Public Health Data Science and Data Equity at the school. Prior to joining Yale University in 2024, Dr. Mukherjee built a distinguished career at the University of Michigan where she was appointed as John D. Kalbfleisch Distinguished University Professor of Biostatistics and the first woman Chair of the Department of Biostatistics (2018-2024). She is known for her contribution to statistical methods for integration of genetic, environmental, and disease data from large healthcare databases and for her work on COVID-19 in India. She is the winner of many awards, including
the 2023 Karl Peace award from the American Statistical Association, and the 2024 Marvin Zelen Leadership in Statistical Science award from Harvard Biostatistics. She is a fellow of the ASA, IMS, AAAS, and an elected member of the US National Academy of Medicine. She has written more than 435 articles and supervised 25 PhD and 7 post-doctoral fellows. She is the founding director of several flagship undergraduate summer programs on big data. She is the 2026 President of ENAR, an eminent professional society for biostatisticians.

Zanvyl Krieger Professor; and Director, Center on the Early Life Origins of Disease
Johns Hopkins University Bloomberg School of Public Health

Xiaobin Wang, MD, MPH, ScD, is the Zanvyl Krieger Professor in Children’s Health and Professor of Pediatrics at the Johns Hopkins Bloomberg School of Public Health and School of Medicine. She is the Founder and Director of the Center on the Early Life Origins of Disease and Founder and Principal Investigator of the Boston Birth Cohort, a large, long-standing NIH-funded prospective multigenerational birth cohort. Dr. Wang has led numerous transdisciplinary, multi-institutional initiatives. Her research integrates diverse environmental exposures (e.g., ambient pollution, neighborhood and home environments, environmental chemicals, nutrition, lifestyle, and psychosocial factors) with multi-omics approaches (genomics, epigenomics, metabolomics, proteomics, and mitochondrial biology) to elucidate how early-life exposures influence underlying biology and shape the developmental trajectories of chronic diseases across the life course and generations, including cardiometabolic, neurodevelopmental, and immune-related conditions. Dr. Wang’s pioneering work has advanced understanding of gene–environment interactions during critical developmental windows—from preconception through early childhood—and their impact on long-term health and chronic disease risk. Her research generates foundational evidence to inform primordial and primary prevention of chronic diseases, emphasizing early developmental windows when prevention is most effective and cost-efficient. Dr. Wang is an elected member of the National Academy of Medicine (Class of 2018).

Advancing Chronic Disease Prevention

Professor and Dean, University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science
PANEL MODERATOR

Cheryl A.M. Anderson, PhD, MPH, is Professor and Founding Dean of the Herbert Wertheim School of Public Health and Human Longevity Science at the University of California San Diego, with a joint appointment in the Department of Medicine Division of Nephrology and Hypertension and the Department of Radiation Medicine and Applied Sciences. She holds the Hood Family Endowed Dean’s Chair in Public Health. Dr. Anderson’s research is focused on nutrition to prevent cardiovascular diseases, chronic kidney disease, and diet-related cancers. The Anderson lab at UC San Diego is currently conducting studies that use community-driven research methods and clinical epidemiology. The body of collaborative work from the Anderson Lab that was focused on dietary sodium, blood pressure, and cardiovascular health has influenced behavioral strategies for the prevention and management of cardiovascular diseases and chronic kidney disease. Dr. Anderson’s public health policy work has included service on the National Academy of Medicine’s Food and Nutrition Board, and the US Dietary Guidelines Advisory Committee. These efforts have influenced population health policies to improve diet quality globally. Dr. Anderson is a deputy editor for Diabetes Care journal and serves on the editorial committee for the Annual Review of Nutrition. In recognition of her scholarship and its impact, she was elected to the National Academy of Medicine in 2016 and to the Council on Foreign Relations in 2021.

Associate Professor in the Department of Physical Medicine and Rehabilitation
Harvard Medical School

Beth Frates, MD, is a trained physiatrist, health and wellness coach, and nationally recognized leader in Lifestyle Medicine. An Associate Professor at Harvard Medical School, she has received multiple teaching awards from Harvard Medical School and Harvard Extension School. She has served as President of the American College of Lifestyle Medicine. A pioneer in the field, Dr. Frates created the first Lifestyle Medicine Interest Group at Harvard Medical School in 2008 and later developed a Lifestyle Medicine curriculum for Harvard Extension School. She has authored and co-authored numerous educational resources, including The Lifestyle Medicine Handbook: An Introduction to the Power of Healthy Habits, The Teen Lifestyle Medicine Handbook, and Lifestyle Medicine curricula for college and secondary-school students. Dr. Frates also developed PAVING the Path to Wellness™, a 12-step wellness program for patients and providers. In 2003 she co-authored the Lifestyle Medicine Pocket Guide and co-edited the book Empowering Behavior Change in Patients. Most recently, in June 2024, she co-edited the book Essentials of Clinical Nutrition in Healthcare and most recently, she co-authored the book PAVING the Path to Wellness Workbook: A Guide to Thriving with a Healthy Body, Peaceful Mind and Joyful Heart (Second Edition). Dr. Frates has her own Lifestyle Medicine consulting/coaching practice where she sees patients 1:1 and in groups.

Rehnborg Farquhar Professor of Medicine
Stanford University

Christopher Gardner, PhD, Rehnborg Farquhar Professor of Medicine at Stanford, has been a nutrition scientist for more than 30 years. He has studied what to consume and to avoid for optimal health, and how best to motivate individuals to achieve healthy dietary behaviors. He recently completed a 2-year term serving on the US Dietary Guidelines Advisory Committee and is the past chair of the American Heart Association’s Nutrition Committee. Professor Gardner has conducted and published dozens of human nutrition intervention trials, including trials of Mediterranean, Ketogenic, Vegan, Low-Fat and Low-Carb diets and their effects on cardiometabolic health. Some of his current
interests include Stealth Nutrition, Unapologetic Deliciousness and Institutional Food Settings. He is currently working on personalized nutrition explorations with several colleagues, with particular focus on the gut microbiome. Professor Gardner’s work was recently featured in an Emmy winning Netflix docuseries (Jan 2024) – “You Are What You Eat: A Twin Experiment”. His book titled Food Sense – What to Eat and Why was published in October 2026.

George A Weiss University Professor
University of Pennsylvania

Karen Glanz, PhD, MPH, is George A. Weiss University Professor, in the Perelman School of Medicine and the School of Nursing, at the University of Pennsylvania (UPenn). Prior to joining the University of Pennsylvania, Glanz was  a Professor at Emory University (2004-2009), University of Hawaii (1993-2004), and Temple University (1979-1993). She is Director of the UPenn Prevention Research Center, Program Co-Leader for the Cancer Control Program at the Abramson Cancer Center (ACC) and has been Director of the Community Engagement and Research (CEAR) Core of the Penn/CHOP CTSA since 2011. Her basic and translational research focuses on applying theories of health
behavior, obesity, nutrition, skin cancer prevention; and the built environment; reducing health disparities; community engagement; and dissemination and implementation science. Glanz has led externally supported research, funded for over $45 million. Her research and publications about understanding, measuring and improving healthy food environments, beginning in the 1980’s, has been widely recognized and replicated. She has published over 570 articles and chapters and is lead Editor on six editions of the widely used text, Health Behavior: Theory, Research and Practice (Wiley/Jossey-Bass: 1990 to 2024). Among her honors and recognitions, she was named by Clarivate as a Highly Cited Researcher (top 1% most cited in her subject field); named among The World’s Most Influential Scientific Minds; and elected as a Fellow of the College of Physicians of Philadelphia. Dr. Glanz was elected to membership in the National Academy of Medicine in 2013.

Science of Health Professor of Behavioral Medicine
Columbia University

Martin Picard, PhD, is Professor at Columbia University Irving Medical Center where he leads the Mitochondrial Psychobiology Group (www.picardlab.org) and co-directs the Columbia Science of Health Program. Martin’s life is dedicated to research, innovation, and communication, translating insights from mitochondrial science into meaningful frameworks for scientists, clinicians, and the public. His laboratory discovered physical mechanisms of mitochondrial communication, produced the first atlas of human brain mitochondrial diversity, demonstrated the reversibility of hair graying, and showed how mitochondria regulate how quickly cells age. Linking mitochondrial bioenergetics and mental health, his research has uncovered converging lines of evidence linking mitochondria to mental states, spawning an energetic view of the mind. Collectively, Martin’s work with his international network of collaborators has led to Mitochondrial Psychobiology: an emerging field of research that reframes mitochondria as dynamic processors that transform and pattern energy to shape life, lived experiences, and our ability to heal. Martin articulates a scientifically-informed, energetically-inspired perspective on health in the forthcoming ENERGY book. He is the Founder and President of the 501(c)(3) nonprofit Energy and Healing Institute | EHI, whose mission is to build the systems and technologies that let us understand and leverage the healing process, empowering all people to flourish and fulfill their unique potential.

Transforming Chronic Disease Treatment and Care

Senior Investigator at NIH; and Chief of the Molecular Immunology and Inflammation Branch, and NIAMS Emeritus Scientific Director
PANEL MODERATOR

John J. O’Shea, MD, is a Senior Investigator at NIH, Chief of the Molecular Immunology and Inflammation Branch, and NIAMS Emeritus Scientific Director. Dr. O’Shea served as Acting Director of the NIH Center for Regenerative Medicine and served in the U.S. Public Health Service Commissioned Corps, from which he received an honorable discharge. Dr. O’Shea was Founding Director of the NIH/Oxford Graduate Program in Biomedical Science. Dr. O’Shea has made fundamental discoveries related to basic mechanisms underlying cytokine signal transduction and key aspects of the JAK-STAT pathway. He discovered mutations as a cause of severe combined immunodeficiency and other autoinflammatory disorders. These insights led to the development of the first JAK inhibitor approved for the treatment of autoimmune, inflammatory, and allergic diseases. Dr. O’Shea elucidated key mechanisms controlling helper T cells and how cytokines influence the epigenome. Among Dr. O’Shea’s numerous awards include: the NIH Director’s Award (eight times), the US Public Health Service Physician Researcher of the Year Award, the Irish Immunology Public Lecture Award, the Arthritis Foundation’s Howley Prize, the Ross Prize in Molecular Medicine, the Milstein Prize for Cytokine and Interferon Research, AAI-Steinman Award for Human Immunology, and the ASCI-Harrington Prize. Dr. O’Shea was elected as a member of the Â鶹´«Ă˝×ĘÔ´, National Academy of Medicine, National Academy of Inventors, American Academy of Arts and Sciences, American Association of Physicians, and a Master of the American College of Rheumatology. He has served on the editorial boards of numerous journals including the Journal of Biological Chemistry, Blood, Journal of Immunology, Immunity, Journal of Experimental Medicine, and Science Immunology.

Director, University of California, San Francisco (UCSF) Weill Institute for Neurosciences; and Professor, Department of Neurology, UCSF

Stephen L. Hauser, MD, is a Professor of Neurology and Director of the University of California, San Francisco (UCSF) Weill Institute for Neurosciences, linking the clinical and basic neurosciences at UCSF to accelerate research against neurologic diseases. Dr. Hauser’s research has advanced our understanding of the genetics, immunology, and treatment of multiple sclerosis (MS). His work led to the development of B cell therapies for MS patients, representing a powerful new approach for relapsing forms of the disease and the first effective therapy for progressive MS. Dr. Hauser is a member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American
Academy of Physicians. He is an editor of the textbook Harrison’s Principles of Internal Medicine. Previously chairman of the Department of Neurology at UCSF for 25 years, he has also served as President of the American Neurological Association, President of the Medical Staff at UCSF, Chair of the Research Advisory Committee for the VA, and editor-in-chief of Annals of Neurology. He also served the Obama administration as a member of the Presidential Commission for the Study of Bioethical Issues charged with advising the President on issues that may emerge from advances in biomedicine and related areas of science and technology. His awards and honors include the Jacob Javits Neuroscience Investigator Award; John Dystel Prize for Multiple Sclerosis Research (2008); Charcot Award (2013); Taubman Prize for Excellence in Translational Medical Research (2017); Scientific Breakthrough Award from the American Brain Foundation (2022); and Breakthrough Prize in Life Sciences (2025).

James A. Baker III Institute Chair in Health Economics, and Professor
Rice University and Baylor College of Medicine

Vivian Ho, PhD, is the James A. Baker III Institute Chair in Health Economics at Rice University’s Baker Institute for Public Policy, a professor in the Department of Economics at Rice University, and a professor in the Department of Medicine at Baylor College of Medicine. Elected to the National Academy of Medicine (NAM) in 2020, Dr. Ho has begun a two-year appointment serving as chair of the NAM Membership Committee. Dr. Ho’s research examines how health policy, market competition, and economic incentives impact the costs and
quality of healthcare. Her professional leadership has included serving on the Board of Scientific Counselors for the National Center for Health Statistics, a founding board member of the American Society for Health Economists, and the Board of Directors for Community Health Choice. Dr. Ho earned her A.B. in economics from Harvard University, a graduate diploma from The Australian National University, and her Ph.D. in economics from Stanford University.

Harvey and Kate Cushing Professor of Medicine (Endocrinology); and Director Yale Obesity Research Center (Y-Weight)
Yale School of Medicine

Ania M. Jastreboff, MD, PhD, is a physician-scientist, endocrinologist, NYT Best-Selling author, and leader in the scientific development and clinical application of obesity medications. Dr. Jastreboff is the Harvey and Kate Cushing Professor of Medicine and Pediatrics at Yale School of Medicine and founding director of the Yale Obesity Research Center (Y-Weight) where she leads pivotal obesity pharmacotherapy trials and NIH-funded studies. She has served as lead investigator for trials investigating nutrient-stimulated hormone (NuSH)-based therapies such as tirzepatide, retatrutide, and maritide. Trained in both adult endocrinology and pediatric endocrinology at Yale and attaining board certification in five specialties, she helped develop Obesity Care Clinical Practice Guidelines, served on The Obesity Society’s Board of Governance, and serves as codirector of Yale Center for Weight Management, where she sees patients. She is a compassionate advocate for patients with obesity from grass-roots patient groups to interviews with Oprah Winfrey on CBS Sunday, TODAY, and The View. She’s a NYT Best-Selling author of Enough: Your Health, Your Weight, and What It’s Like to Be Free by Ania Jastreboff, MD, PhD & Oprah Winfrey.

D. H. Chen Professor of Neurology and Neurological Sciences
Stanford University

Tony Wyss-Coray, PhD, is the D.H. Chen Distinguished Professor of Neurology and Neurological Sciences and the Director of the Phil and Penny Knight Initiative for Brain Resilience at Stanford University. His lab studies brain aging and neurodegeneration with a focus on age-related cognitive decline and Alzheimer’s disease. The Wyss-Coray research team discovered that circulatory blood factors can modulate brain structure and function and factors from young organisms can rejuvenate old brains. Current studies focus on the molecular basis of the systemic communication with the brain by employing a combination of genetic, cell biology, and –omics approaches in mice, and humans. Wyss-Coray has presented his ideas at Global TED, the Tencent WE Summit, the World Economic Forum, and he was voted Time Magazine’s “The Health Care 50” most influential people transforming health care in 2018. He co-founded Alkahest Inc. and several other companies targeting Alzheimer’s and neurodegeneration and has been the recipient of an NIH Director’s Pioneer Award, a Zenith Award from the Alzheimer’s Association, and a NOMIS Foundation Award.

 President’s Forum: A Conversation Among Academy Presidents

Monica Bertagnolli
President, National Academy of Medicine; Chair, NAM Council

Monica M. Bertagnolli, MD, is the President of the National Academy of Medicine (NAM) and Chair of the NAM Council. A surgical oncologist and physician-scientist, her research has advanced understanding of the role of genetics and inflammation in gastrointestinal cancers and soft-tissue sarcomas. She served as director of the National Cancer Institute before becoming director of the NIH and earlier held academic and clinical leadership roles at Harvard Medical School/Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. A past president and chair of the board of directors for the American Society of Clinical Oncology, she has also served on the boards of the American Cancer Society and the Prevent Cancer Foundation.

Bertagnolli has championed collaborative efforts to build a learning health system by transforming the data infrastructure for clinical research, including by spearheading the mCODE initiative, which enabled standardized oncology data exchange, and DataCOUNTS, an NIH program managing data to drive a learning health system. She is also a strong advocate for increasing the representation of clinical trial participants, particularly from rural and remote communities.

A native of rural Wyoming, Bertagnolli was elected as a member of the National Academy of Medicine in 2021. She is the first woman to serve as president of the NAM since its establishment as the Institute of Medicine in 1970.

The daughter of first-generation Italian and French Basque immigrants, Dr. Bertagnolli grew up on a ranch in southwestern Wyoming. She graduated from Princeton University with a Bachelor of Science in Engineering degree and attended medical school at the University of Utah. She trained in surgery at Brigham and Women’s Hospital and was a research fellow in tumor immunology at the Dana-Farber Cancer Institute.

President, National Academy of Engineering

Tsu-Jae King Liu, PhD, is a distinguished engineer and academic leader, she earned her BS, MS, and PhD degrees in electrical engineering from Stanford University. In 1996 she joined the faculty of the Department of Electrical Engineering and Computer Sciences at the University of California, Berkeley where she has served in various administrative leadership positions, most recently as Dean of the College of Engineering from July 2018 through June 2025. Liu has made seminal contributions to semiconductor technology, which include co-developing the FinFET transistor design, foundational to advanced microprocessor chips, that are used in all leading-edge computer chips and smartphones. She has authored over 550 publications and holds 97 U.S. patents. Her research excellence has been honored through numerous awards, including the DARPA Significant Technical Achievement Award, the Intel Outstanding Researcher in Nanotechnology Award, and the IEEE Electron Devices Society Education Award. Liu is a Fellow of the IEEE and the National Academy of Inventors. She has served on the Boards of Directors for Intel Corporation and MaxLinear Inc., and has contributed nationally as an advocate for domestic microelectronics workforce development and as a member of advisory committees for NSF, NIST, and PCAST. Through her leadership, vision, and advocacy, she continues to drive innovation in engineering and champion collaboration in education and workforce development to meet the skilled technical talent needs of U.S. industry. She was inducted into the National Academy of Engineering in 2017 and assumed its Presidency on July 1, 2025.

President, Â鶹´«Ă˝×ĘÔ´

Neil H. Shubin, PhD, is an evolutionary biologist and the 23rd president of the Â鶹´«Ă˝×ĘÔ´. He is a renowned scientist, educator, author, and science communicator. Previously, he was the Robert R. Bensley Distinguished Service Professor of Organismal Biology and Anatomy and vice dean for academic advancement at the University of Chicago, where he led a dynamic multidisciplinary research laboratory that has integrated breakthroughs in paleontology with an understanding of the molecular biology of development. He also held faculty and senior leadership posts at the University of Pennsylvania, the Marine Biological Laboratory in Woods Hole, Massachusetts, and the Field Museum in Chicago. He is best known for his critically acclaimed book Your Inner Fish, which shares his insights as a fish paleontologist teaching a human anatomy lab and on the expedition, he led that made the breakthrough discovery of Tiktaalik ­— a fossil representing an intermediate body plan between fish and amphibians. The book was later turned into an Emmy-award winning miniseries on PBS. He earned his bachelor’s degree in biology from Columbia College of Columbia University in 1982 and a PhD in organismic and evolutionary biology from Harvard University in 1987.

Speakers’ Conflict of Interest Disclosures

Drew Altman, PhD
None noted.

Cheryl A.M. Anderson, PhD, MPH
Grant/Research Support – AHA/RWJF, NIH K24, NIH R13

Monica M. Bertagnolli, MD
None noted.

Ebony Boulware, MD, MPH
None noted.

Luigi Ferrucci, MD, PhD
None noted.

Beth Frates, MD
None noted.

Christopher Gardner, PhD
None noted.

Karen Glanz, PhD, MPH
None noted.

Bridget Goosby, PhD
None noted.

Stephen L. Hauser, MD

  • Grant/Research Support – Grant support from NIH/NINDS, NMSS, Valhalla Foundation, and C.D. Spangler Foundation
  • Salary/Consultant Fee – Serve on scientific advisory boards of Accure, Alector, Hinge Bio; and advisor for Neurona
  • Stocks/Bonds – Stock options previously received from Alector and Neurona as part of roles noted above

Vivian Ho, PhD
None noted.

Ania M. Jastreboff, MD, PhD

  • Grant/Research Support – Conducts global multi-center trials (contracts through institution): Amgen, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, Rhythm Pharmaceutical, Roche/Genentech, and National Institutes of Health
  • Salary/Consultant Fee – Serves as Scientific Advisor and/or on Scientific Advisory Boards for Amgen, AstraZeneca, Boehringer Ingelheim, Biohaven, Eli Lilly and Company, Goldman Sachs Life Sciences, i2o, Intellihealth/Flyte, Metsera, Novo Nordisk, Pfizer, Regeneron, Roche/Genentech, Scholar Rock, Structure Therapeutics, Syntis Bio, Viking, Wave, WeightWatchers International, and Zealand Pharmaceuticals
  • Stocks/Bonds – Intellihealth/Flyte, Syntis Bio, Metsera, and State 4 Therapeutics
  • Honorarium/Expenses – Travel support from Novo Nordisk, Boehringer Ingelheim, Eli Lilly and Company, WW International, Zealand Pharmaceuticals

Brendan Lee, MD, PhD
None noted.

Tsu-Jae King Liu, PhD
None noted.

Bhramar Mukherjee, PhD
None noted.

John O’Shea, MD
None noted.

Martin Picard, PhD
Grant/Research Support – NIH, Baszucki Group

Neil H. Shubin, PhD
None noted.

Xiaobin Wang, MD, MPH, ScD

  • Grant/Research Support – NIH, HRSA research grants
  • Salary/Consultant Fee – Faculty, Johns Hopkins Univ
  • Honorarium/Expenses – NIH/NIEHS, All of Us Program, Spark NS

Tony Wyss-Coray, PhD
None noted.

Secret Link